Blog
How Dutch Pharma Companies Can De-Risk CAPEX Projects Through Structured Consultancy Models
Why CAPEX Projects in Dutch Pharma Are Becoming Harder and What Companies are Doing About It A few months ago, we were speaking with someone leading a facility expansion project for a pharmaceutical company in the Netherlands. The conversation started the way these conversations usually do timelines, construction phases, equipment delivery schedules. Dutch Pharma CAPEX…
Read MoreWhat Investors Look for in Life Sciences Leadership Teams
Introduction: A Hard Truth We See in the Dutch Market Let’s start with something we’ve observed repeatedly across the Netherlands life sciences ecosystem. A company can have exceptional science published research, promising data, strong academic backing and still struggle to secure investment. Why? Because investors are not only funding innovation. They are funding the people…
Read MoreHow High-Performing Life Sciences Teams Are Built, Not Found
High Performance is rare and in the Netherlands, It’s Earned If you look at global research, only around 30% of teams are considered truly high performing. In innovation-heavy sectors like Life Sciences, the bar is even higher. Here in the Netherlands, the pressure is tangible. From biotech scale-ups in Leiden to MedTech innovators in Eindhoven…
Read MoreThe Hidden Cost of Leadership Vacancies in High-Growth Life Sciences Companies
Growth Is Strong in the Netherlands. Leadership Gaps Are Not. The Netherlands has built one of Europe’s most competitive innovation ecosystems. But leadership vacancies in Netherlands life sciences companies are becoming an increasingly underestimated risk to growth. In high-growth biotech and pharmaceutical organizations, an executive gap is rarely just an HR issue, it is a…
Read MoreFrom Strategy to Execution: Closing the Gap in Life Sciences Transformation Projects
Introduction: Why Great Strategy is no longer enough Across the Netherlands life sciences ecosystem, we see the same pattern again and again. Strong strategies are approved. Transformation programs are launched. Budgets are allocated and yet months later progress slows, teams become frustrated and the original ambition starts to quietly erode. The uncomfortable truth? Most life…
Read MoreDigital Transformation Fails Without People Strategy
Lessons from the Netherlands Life Sciences Industry Digital transformation is no longer optional in the Dutch life sciences sector. Whether you’re operating in biotech, pharma, medtech or advanced diagnostics the pressure is the same: move faster, use data better and scale innovation without compromising quality. Yet despite record investments in platforms, AI tools and digital…
Read MoreWhy Project-Based Talent Models Are Replacing Traditional Hiring in Life Sciences
Introduction: A Problem I See Repeating Across the Netherlands Over the past few years, we have had countless conversations with HR Directors, Talent Acquisition leaders and CEOs across the Dutch Life Sciences ecosystem from biotech scale-ups in Leiden to established pharma organizations in Utrecht and Oss. Different companies. Different stages. But the same frustration keeps…
Read MoreThe New Leadership Profile in Life Sciences: Skills That Matter in 2026
Leadership in Dutch Life Sciences Is Being Tested, Not Redefined We hear a lot of talk about future leadership. Most of it sounds impressive. Very little of it feels real. Over the past year, we have sat in meeting rooms across the Netherlands biotech scale-ups, pharma subsidiaries, MedTech innovators and the pattern is strikingly similar.…
Read MoreHow Life Sciences Companies in the Netherlands are Redesigning Operating Models for Scale
Introduction: Scale Is Where Good Life Sciences Companies Start to Struggle Over the past few years, we have had countless conversations with leadership teams across the Netherlands life sciences ecosystem from fast-growing biotech scale-ups in Leiden and Utrecht to established pharma and MedTech organizations operating globally from Dutch hubs. What we hear again and again…
Read MoreBest Workforce Practices for Regulated Life Sciences Companies at Pivot Park OSSC
Introduction: Why Workforce Strategy Is Now a Growth Issue in the Netherlands If there’s one thing we have learned from working closely with life sciences organizations across the Netherlands, it’s this: growth rarely fails because of science, it fails because of people’s strategy. At innovation hubs like Pivot Park OSSC, companies are scaling fast. New…
Read More